Incidental Abnormal FDG Uptake in the Prostate on 18-fluoro-2-Deoxyglucose Positron Emission Tomography-Computed Tomography Scans |
Kang, Pil Moon
(Department of Urology, Busan Paik Hospital, Inje University)
Seo, Won Ik (Department of Urology, Busan Paik Hospital, Inje University) Lee, Sun Seong (Department of Nuclear Medicine, Busan Paik Hospital, Inje University) Bae, Sang Kyun (Department of Nuclear Medicine, Busan Paik Hospital, Inje University) Kwak, Ho Sup (Department of Urology, Dong Eui Medical Center) Min, Kweonsik (Department of Urology, Busan Paik Hospital, Inje University) Kim, Wansuk (Department of Urology, Busan Paik Hospital, Inje University) Kang, Dong Il (Department of Urology, Busan Paik Hospital, Inje University) |
1 | Godoy A, Ulloa V, Rodriguez F, et al (2006). Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J Cell Physiol, 207, 614-27. DOI ScienceOn |
2 | Bouchelouche K, Oehr P (2008). Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. J Urol, 179, 34-45. |
3 | Effert P, Beniers AJ, Tamimi Y, et al (2004). Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma. Anticancer Res, 24, 3057-63. |
4 | Effert PJ, Bares R, Handt S, et al (1996). Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol, 155, 994-8. DOI |
5 | Han EJ, H OJ, Choi WH, et al (2010). Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images. Br J Radiol, 83, 915-20. DOI ScienceOn |
6 | Hasbek Z, Yucel B, Salk I, et al (2014). Potential impact of atelectasis and primary tumor glycolysis on F-18 FDG PET/CT on survival in lung cancer patients. Asian Pac J Cancer Prev, 15, 4085-9. 과학기술학회마을 DOI |
7 | Hofer C, Laubenbacher C, Block T, et al (1999). Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol, 36, 31-5. |
8 | Lawrentschuk N, Davis ID, Bolton DM, et al (2006). Positron emission tomography and molecular imaging of the prostate: an update. BJU Int, 97, 923-31. DOI |
9 | Hoh CK, Seltzer MA, Franklin J, et al (1998). Positron emission tomography in urological oncology. J Urol, 159, 347-56. DOI |
10 | Hwang I, Chong A, Jung SI, et al (2013). Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomographycomputed tomography images? Ann Nucl Med, 27, 140-5. DOI |
11 | Kao PF, Chou YH, Lai CW (2008). Diffuse FDG uptake in acute prostatitis. Clin Nucl Med, 33, 308-10. DOI |
12 | Levi J, Cheng Z, Gheysens O, et al (2007). Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem, 18, 628-34. DOI |
13 | Minamimoto R, Uemura H, Sano F, et al (2011). The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level. Ann Nucl Med, 25, 21-7. DOI ScienceOn |
14 | Oyama N, Akino H, Suzuki Y, et al (1999). The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer. Jpn J Clin Oncol, 29, 623-9. DOI ScienceOn |
15 | Piccardo A, Paparo F, Picazzo R, et al (2014). Value of fused (18) F-choline-PET/MRI to evaluate prostate cancer relapse in patients showing biochemical recurrence after ebrt: preliminary results. Biomed Res Int, 2014, 103718. |
16 | Picchio M, Berardi G, Fodor A, et al (2014). (11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients. Eur J Nucl Med Mol Imaging, 41, 1270-9. |
17 | Powles T, Murray I, Brock C, et al (2007). Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol, 51, 1511-20; discussion 20-1. DOI ScienceOn |
18 | Zhao JY, Ma XL, Li YY, et al (2014). Diagnostic Accuracy of 18F-FDG-PET in patients with testicular cancer: a metaanalysis. Asian Pac J Cancer Prev, 15, 3525-31. DOI |
19 | Scher B, Seitz M, Albinger W, et al (2007). Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging, 34, 45-53. DOI |
20 | Reinicke K, Sotomayor P, Cisterna P, et al (2012). Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue. J Cell Biochem, 113, 553-62. DOI |
21 | Shiiba M, Ishihara K, Kimura G, et al (2012). Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT. Ann Nucl Med, 26, 138-45. DOI |
![]() |